CLCamila Miranda Lopes-Ramos

Camila Miranda Lopes-Ramos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Camila Miranda Lopes-Ramos has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lung function change and quantitative CT measurements associate with prospective frailty

    by Eleanor Kate Phillips, Elizabeth Regan, Karin F. Hoth, Bonnie Patchen, Woei-Yuh Saw, Camila M. Lopes-Ramos, Barry Make, Jessica Bon, Abebaw Mengistu Yohannes, Nicola A. Hanania, et al.

    Background: Frailty, a state of reduced physiologic reserve, is associated with comorbid lung disease. Its relationship with lung function change over time and with lung computed tomography (CT) measurements is less clear. Methods: COPDGene, a multicenter cohort study, enrolled adults aged 45–80 with a minimum 10 pack-year smoking history. This study included participants with normal baseline six-minute walk distance, spirometry at all three site visits, and frailty assessment. The primary exposures were baseline quantitative CT measurements (airway wall thickening[Pi10], log 10 (% emphysema), pulmonary artery[PA] enlargement, and relative volume in the small pulmonary vasculature[BV5/TBV]) and spirometric decline over the 10-year study period. The primary outcomes were frailty and prefrailty at 10-year follow-up (defined using a modified Fried Frailty Phenotype). Secondary analyses evaluated associations between inflammatory markers and frailty and for mediation of these associations by spirometric decline. Results: Among 2354 participants, 1200(51%) were prefrail and 297(13%) were frail at 10-year follow-up. Baseline Pi10, log 10 (% emphysema), and PA enlargement were significantly associated with increased odds of frailty (adjusted OR[95% CI], respectively: 1.52[1.30–1.77], p<0.001; 1.38[1.14–1.67], p<0.001; 2.49[1.41–4.41], p=0.002), as was lower BV5/TBV, an indicator of pulmonary vascular pruning (OR 0.59[0.48–0.72], p<0.001). Forced expiratory volume in one second (FEV1) decline was associated with increased odds of frailty (OR 1.47[1.30–1.65], p<0.001 per 1%/year drop). White blood cell count and neutrophil:lymphocyte ratio were associated with frailty; this was partially mediated by spirometric decline. Conclusion: In a population with a cigarette smoking history, lung function decline and CT measurements were associated with prospective frailty risk.

  • Open Access

    Deploying a JupyterHub Server for Academic Research Using Netbooks as an Example

    by Marouen Ben Guebila, Enakshi Saha, Mia Shapoval, Chen Chen, Soel Micheletti, Tara D. Eicher, Viola Fanfani, Jonas Fischer, Katherine H. Shutta, Panagiotis Mandros, et al.

    Jupyter Notebooks have transformed the way we conduct computational research thanks to a versatile platform that combines code, annotations, plots, and a lightweight format that enables versioning. However, steps for installing dependencies and downloading data for a specific notebook may require significant time and failure to establish identical environments can compromise reproducibility of environments. Deploying a JupyterHub server not only provides a containerized environment for each notebook to ensure fast execution and exact reproducibility but also provides a computational engine that makes these applications available from any device. By providing all the steps for deploying a JupyterHub server, and providing our experience deploying and maintaining Netbooks, a server for academic investigations in network biology, we want to encourage other groups to deploy JupyterHub servers for their own computational work and to recognize their value in improving reproducibility, accelerating manuscript review, and supporting education. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol : Setting up a JupyterHub server Support Protocol 1 : Compiling a collection of Jupyter Notebooks Support Protocol 2 : Securing HTTPS access Support Protocol 3 : Adding parameters for JupyterHub Support Protocol 4 : Data management for JupyterHub Support Protocol 5 : Customizing the website homepage Support Protocol 6 : Importing/Exporting conda environments Alternate Protocol : Running a JupyterHub server as a virtual machine

  • Top Cited Papers
    Open Access

    Sex differences in gene regulation and its impact on cancer incidence

    by Camila M. Lopes-Ramos, Rebekka Burkholz, Marouen Ben Guebila, Viola Fanfani, Enakshi Saha, Katherine H. Shutta, Kimberly Glass, John Quackenbush, Dawn L. DeMeo


  • Open Access

    Intrinsic microRNA regulatory programs define lineage-specific differentiation in human mesenchymal stem cells of different origin – dental pulp- and fat tissue-derived

    by Carla Cristina G. Pinheiro, Camila M. Lopes-Ramos, Taro Inagaki, Paula Fontes Asprino, José Ricardo M. Ferreira, Ygor Gonçalves Félix de Mattos, Helena Coutinho Geiger Campos, Jamil Award Shibli, Raphael B. Parmigiani, Reza Jarrahy, et al.

    Cell fate determination and terminal differentiation are shaped by intrinsic molecular programs that coordinate lineage-specific gene expression. In mesenchymal stem cells (MSCs), variability in osteogenic efficiency among distinct tissue sources remains poorly understood and cannot be fully explained by differentiation conditions alone. Increasing evidence indicates that post-transcriptional regulatory mechanisms, particularly those mediated by microRNAs (miRNAs), are closely associated with differentiation outcomes. Here, we investigated whether intrinsic miRNA expression landscapes are associated with lineage-associated differences in late-stage mineralization, in the context of potential donor-related variability of human MSCs. Dental pulp stem cells (DPSCs) and processed lipoaspirate (PLA)-derived MSCs were cultured under identical osteogenic induction conditions and analyzed longitudinally throughout differentiation. Both cell populations fulfilled established mesenchymal phenotypic criteria and successfully initiated osteogenic commitment. However, DPSCs exhibited significantly enhanced extracellular matrix mineralization at mid-to-late stages of differentiation, suggesting divergence at later stages of extracellular matrix mineralization rather than at early lineage commitment. Temporal small RNA sequencing performed at days 0, 7, 14, and 21 revealed progressive remodeling of miRNA expression in both MSC sources. Direct comparison at the mature osteoblast stage identified a discrete set of ten miRNAs differentially expressed between DPSCs and PLA-derived cells. DPSCs displayed reduced expression of several miRNAs previously associated with inhibitory roles in osteogenic pathways. Network-based analyses indicated convergence of these miRNAs on gene programs involved in skeletal development and extracellular matrix organization. Targeted validation confirmed decreased expression of miR-10a-5p and miR-196a-5p, accompanied by increased expression of osteogenesis-associated genes, including BMP1 and MMP16, in DPSCs. Collectively, these findings show that lineage-specific miRNA expression patterns are associated with distinct osteogenic maturation trajectories in human MSCs. This work identifies an intrinsic post-transcriptional signature through which cellular origin may influence terminal differentiation outcomes and suggests that such miRNA profiles may serve as informative molecular biomarkers in the future for the selection and characterization of mesenchymal stem cells intended for human bone tissue engineering applications.


  • Open Access

    Sex differences in gene regulation and its impact on cancer incidence

    by Camila M. Lopes-Ramos, Rebekka Burkholz, Marouen Ben Guebila, Viola Fanfani, Enakshi Saha, Katherine H. Shutta, Kimberly Glass, John Quackenbush, Dawn L. DeMeo

    Sex differences in the incidence rates of many cancer types are well-documented. While differences in lifestyle, environmental exposures, and hormone levels can influence disease risk and incidence, there is limited understanding of how cancer driver genes are differentially regulated between males and females in normal tissues, and how these differences may contribute to the observed sex differences in cancer epidemiology. We studied 8,279 gene regulatory networks across 29 non-cancerous tissues in the GTEx dataset, referred here as normal tissues. Using network centrality measures, we compared the networks between males and females, focusing on interactions between 644 transcription factors and 476 cancer genes (COSMIC Cancer Gene Census). Cancer genes were differentially targeted by transcription factors in males and females across normal tissues. We found an overrepresentation of sex-biased cancer genes on the X chromosome, particularly among genes escaping X chromosome inactivation, with higher regulatory targeting of tumor suppressor genes in females compared to males. Key signaling pathways, including WNT, NOTCH, and p53, showed differential transcriptional targeting by sex. We observed higher targeting of cancer-related pathways in females for tissues that have higher tumor incidence in females (breast, lung, and thyroid) and higher targeting in males for tissues with increased tumor incidence in males (stomach, colon, and liver). Sex-biased transcription factors that were consistently observed across multiple tissues are enriched for sex hormone response elements in their promoters. Our findings showed that normal tissues have sex-biased regulation of genes implicated in tumorigenesis, helping to explain the molecular basis of sex differences observed in cancer incidence rates and in identifying targets for cancer prevention in a sex-aware manner.

  • Open Access

    Sex differences in thyroid aging and their implications in thyroid disorders: insights from gene regulatory networks

    by Enakshi Saha, Marouen Ben-Guebila, Chen Chen, Viola Fanfani, Katherine Hoff Shutta, Dawn L DeMeo, John Quackenbush, Camila M Lopes-Ramos

    Thyroid disorders are more prevalent in females than males, with sex differences in disease risk varying by age, e.g. although risk of anaplastic thyroid carcinoma (ATC) increases with age for both sexes, females are diagnosed at younger ages than males. In contrast, Hashimoto’s thyroiditis (HT) is more common in ages 30-50, with females having higher risk. These patterns suggest that in thyroid, gene regulatory processes evolve with age in a sex-specific manner. To characterize these sex differences in thyroid aging, we estimated and analyzed individual-specific gene regulatory networks using BONOBO and PANDA algorithms. We found that regulatory patterns of pathways involved in cell proliferation, immune response, and metabolic processes vary nonlinearly with age, with sex-specific differences in direction and rate. Females show two inflection points around ages 40 and 60, when regulatory patterns show significant change for most pathways, consistent with changes in targeting by estrogen and androgen receptors. Investigating gene regulatory patterns in HT and ATC, we observed that disease-relevant immune and metabolic pathways changed with age in the same direction as they change in ATC. In contrast, in HT, disease-related regulatory patterns are in the opposite direction of aging. In age groups where HT is most diagnosed, regulatory patterns in females more closely resembled disease states than males, highlighting sex-biased regulation’s role in elevated disease risk in females. Our findings demonstrate immune response and metabolic processes are regulated in age- and sex-specific manner, potentially driving variation in disease risk, emphasizing the need for tailored screening and prevention strategies. Abstract Figure:


  • Open Access

    Multi-omics protein signaling networks identify sex-specific therapeutic candidates in lung adenocarcinoma

    by Chen Chen, Enakshi Saha, Jonas Fischer, Marouen Ben Guebila, Viola Fanfani, Katherine H. Shutta, Megha Padi, Kimberly Glass, Dawn L. DeMeo, Camila M. Lopes-Ramos, et al.

    Background: Lung adenocarcinoma shows distinct differences between males and females in incidence, prognosis, and treatment response, suggesting unique molecular mechanisms that remain underexplored. This study aims to identify sex-specific molecular signatures and therapeutic targets in lung adenocarcinoma using multi-omics approaches to inform personalized treatment strategies. Methods: We conducted an integrative analysis of transcriptomic and proteomic data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and The Cancer Genome Atlas (TCGA) datasets, comparing male and female lung adenocarcinoma profiles. Transcription factor activity was assessed using TIGER on gene expression data, while kinase activity was evaluated with PTM-SEA on proteomic data. These results were combined to build a kinase-transcription factor signaling network. Potential sex-specific drugs were identified using the PRISM drug screening database. Results: The analysis revealed significant sex-based differences in transcription factor and kinase activity. Notably, NR3C1, AR, and AURKA exhibited sex-biased expression and activity. The constructed signaling network highlighted druggable pathways linked to cancer-related processes, with distinct profiles in males and females. PRISM screening identified glucocorticoid receptor agonists and aurora kinase inhibitors as promising sex-specific therapeutic candidates. Conclusions: Our findings underscore the importance of considering sex differences in lung adenocarcinoma molecular profiles. The integration of transcriptomic and proteomic data reveals sex-specific pathways and potential therapies, paving the way for personalized treatment approaches tailored to male and female patients.


  • Open Access

    Aging-associated alterations in gene regulatory networks associate with risk, prognosis and response to therapy in lung adenocarcinoma

    by Enakshi Saha, Marouen Ben Guebila, Viola Fanfani, Katherine H. Shutta, Dawn L. DeMeo, John Quackenbush, Camila M. Lopes-Ramos

    Aging is the primary risk factor for many cancer types, including lung adenocarcinoma (LUAD). To understand how aging-related alterations in the regulation of key cellular processes might affect LUAD risk and survival, we built individual-specific gene regulatory networks integrating gene expression, transcription factor protein-protein interaction, and sequence motif data, using PANDA/LIONESS algorithms, for non-cancerous lung samples from GTEx project and LUAD samples from TCGA. In healthy lung, pathways involved in cell proliferation and immune response were increasingly targeted with age; these aging-associated alterations were accelerated by smoking and resembled oncogenic shifts observed in LUAD. Aging-associated genes showed greater aging-biased targeting patterns in individuals with LUAD compared to healthier counterparts, a pattern suggestive of age acceleration. Using drug repurposing tool CLUEreg, we found small molecule drugs that may potentially alter the accelerating aging profiles we found. We defined a network-informed aging signature that was associated with survival in LUAD.


  • Open Access

    Identifying Sex Differences in Lung Adenocarcinoma Using Multi-Omics Integrative Protein Signaling Networks

    by Chen Chen, Enakshi Saha, Jonas Fischer, Marouen Ben Guebila, Viola Fanfani, Katherine H. Shutta, Megha Padi, Kimberly Glass, Dawn L. DeMeo, Camila M. Lopes-Ramos, et al.

    Lung adenocarcinoma (LUAD) exhibits differences between the sexes in incidence, prognosis, and therapy, suggesting underexplored molecular mechanisms. We conducted an integrative multi-omics analysis using the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and The Cancer Genome Atlas (TCGA) datasets to contrast transcriptomes and proteomes between sexes. We used TIGER to analyze TCGA-LUAD expression data and found sex-biased activity of transcription factors (TFs); we used PTM-SEA with CPTAC-LUAD proteomics data and found sex-biased kinase activity. We combined these to construct a kinase-TF signaling network and discovered druggable pathways linked to cancer-related processes. We also found significant sex biases in clinically relevant TFs and kinases, including NR3C1, AR, and AURKA. Using the PRISM drug screening database, we identified potential sex-specific drugs, such as glucocorticoid receptor agonists and aurora kinase inhibitors. Our findings emphasize the importance of considering sex and using multi-omics network methods to discover personalized cancer therapies.


  • Open Access

    Reproducible processing of TCGA regulatory networks

    by Viola Fanfani, Katherine H Shutta, Panagiotis Mandros, Jonas Fischer, Enakshi Saha, Soel Micheletti, Chen Chen, Marouen Ben Guebila, Camila M Lopes-Ramos, John Quackenbush

    Background: Technological advances in sequencing and computation have allowed deep exploration of the molecular basis of diseases. Biological networks have proven to be a valuable framework for analyzing omics data and modeling regulatory interactions between genes and proteins. Large collaborative projects, such as The Cancer Genome Atlas (TCGA), have provided a rich resource for building and validating new computational methods, resulting in a plethora of open-source software for downloading, preprocessing, and analyzing those data. However, for an end-to-end analysis of regulatory networks, a coherent and reusable workflow is essential to integrate all relevant packages into a robust pipeline. Findings: We developed tcga-data-nf, a Nextflow workflow that allows users to reproducibly infer regulatory networks from the thousands of samples in TCGA using a single command. The workflow can be divided into 3 main steps: multiomic data, such as RNA sequencing and methylation, are (i) downloaded, (ii) preprocessed, and (iii) analyzed to infer regulatory network models with the Network Zoo. The workflow is powered by the NetworkDataCompanion R package, a standalone collection of functions for managing, mapping, and filtering TCGA data. Here, we demonstrate how the pipeline can be used to investigate the differences between colon cancer subtypes attributed to epigenetic mechanisms. Lastly, we provide a database of pregenerated networks for the 10 most common cancer types that can be readily accessed by the public. Conclusions: tcga-data-nf is a complete, yet flexible and extensible, framework that enables the reproducible inference and analysis of cancer regulatory networks, bridging a gap in the current universe of software tools for analyzing TCGA data.